A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

BACKGROUND: Long-acting muscarinic antagonist/long-acting β(2)-agonist combinations are recommended for patients whose chronic obstructive pulmonary disease (COPD) is not managed with monotherapy. We assessed the efficacy and safety of glycopyrrolate (GP)/formoterol fumarate (FF) fixed-dose combinat...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Respir Res
मुख्य लेखकों: Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2017
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216561/
https://ncbi.nlm.nih.gov/pubmed/28061907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0491-8
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन